Atlas Trials

A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma

Clinical trial NCT00733889 · COMPLETED

Trial details

NCT number
NCT00733889
Sponsor
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Carcinoma
Start date
2006-12-01
Primary completion
2012-11-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.